| 000 | 01689 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514235355.0 | ||
| 264 | 0 | _c20060130 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/kei046 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSieper, J | |
| 245 | 0 | 0 |
_aPersistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cDec 2005 |
||
| 300 |
_a1525-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBaraliakos, X | |
| 700 | 1 | _aListing, J | |
| 700 | 1 | _aBrandt, J | |
| 700 | 1 | _aHaibel, H | |
| 700 | 1 | _aRudwaleit, M | |
| 700 | 1 | _aBraun, J | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 44 _gno. 12 _gp. 1525-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kei046 _zAvailable from publisher's website |
| 999 |
_c15729467 _d15729467 |
||